Delivery Order SPE2DB22D2214-SPE2DB25FS5YY
- Not listed
- The Defense Logistics Agency awarded a $14,034.53 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- The Defense Logistics Agency awarded a $3,931.20 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price delivery order, with a completion date of July 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded without set-aside designation and will be fulfilled from the vendor's corporate...
- The Defense Logistics Agency awarded a $3,284.65 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Eliquis 5 mg tablets (60-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,719.90 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg on July 24, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $3,484.49. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026. The delivery order carries an ultimate completion date of July...
- The Defense Logistics Agency awarded a $1,310.21 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of September 19, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $39,626.90 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed price contract, which is a child order under a larger indefinite delivery vehicle, requires completion by August 28, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,533.97 for 60 tablets of Eliquis 5 mg on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed price, non-set-aside contract utilizing a competitive award process. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,924.38 on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and calls for ultimate completion by July 21, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5YYDelivery Order
The Defense Logistics Agency awarded a $3,237.09 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on July 29, 2025, with completion expected by July 30, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation and is classified as a child contract, indicating it falls under a larger indefinite delivery contract vehicle. The pharmaceutical will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a routine transaction within AmerisourceBergen's substantial relationship with DLA as a critical pharmaceutical distributor for federal medical procurement. The company holds a $999.999 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical extending through December 2026, which serves as the prime vehicle supporting military healthcare systems globally. Through this framework, AmerisourceBergen supplies an extensive portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating the company's role as a foundational supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/29/25 |